ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 414

High Prevalence Of Obesity Among Early and Established Rheumatoid Arthritis

Ines Colmegna1, Maria Celia Bazan Bardales2, Susan J. Bartlett3 and Carol A. Hitchon4, 1Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 2Rheumatology, McGill University, Montreal, QC, Canada, 3Clinical Epidemiology, McGill University, Montreal, QC, Canada, 4Rheumatology, University of Manitoba, Winnipeg, MB, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: obesity, prevention and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is characterized by early, accelerated atherosclerosis leading to increased disability, morbidity and mortality. Inflammation and traditional cardiovascular (CVD) risk factors contribute to poor outcomes, and obesity further increases risks of CVD, diabetes and disability. New sex-specific RA cutpoints for obesity have been proposed. We estimated the prevalence of obesity among Canadian RA patients using the existing and new thresholds.

Methods: Patients receiving care during 2011-13 at two university centers were included. Height and weight were measured and selected demographic (age, sex, tobacco use), RA (duration, RF+, CCP+, ESR, CRP, tender + swollen joints) and patient reported outcomes (patient global, HAQ, morning stiffness) were obtained at the visit. Patients were classified according to WHO criteria and proposed new RA cutpoints, and results were compared with 2008 StatsCan data.

Results: Participants were 200 RA patients (106 from Winnipeg, 94 from Montreal) who were mostly female (76%) with a mean ± SD age of 56.9 ± 15.3 yr, median [IQR] RA duration of 5 [6] yr (29% < 2 yrs) and HAQ of .7 [IQR 1]. 83% were RF+ and 63% anti-CCP+. Groups did not differ between sites by age, sex or BMI, however, patients in Montreal were more likely to have early RA (38 vs 20%; p =.001) and less likely to have smoked (31% vs. 66%, p <.001).  Women were significantly younger than men (56 ± 16 vs 61 ± 14; p=.025) and less likely to report tobacco use (47 vs. 68%; p=.023). RA duration, HAQ and BMI was similar between sexes. Using WHO, 34% of the RA patients were obese; women with RA had higher rates of obesity than men (see table). Using the proposed RA cutpoints, 55% were classified as obese, and men with RA had higher rates of obesity than women. Demographic and RA characteristics were not significantly (p>.05) different between obese and non-obese patients. Although HAQ was only weakly associated with BMI (r=.311 p< .001), obese patients had more than twice the odds of HAQ scores ≥ 1 (OR 2.3 95% CI 1.2, 4.2).

Conclusion: Our results suggest that Canadian RA patients are more likely to be obese than their peers and men appear to be at particular risk. Obesity in RA is associated with greater rates of self-reported disability. Identifying and addressing obesity among newly and established RA patients may be relevant to reduce the excess CVD-associated morbidity and mortality associated with this disease.

 

 

All

Men

Women

Canadian Population (2008)

24.1%

24.3%

23.9%

Rheumatoid Arthritis

 

 

 

   BMI ≥ 30

34%

29%

36%

   Risk Ratio (95 Confidence         Interval)

1.4 (0.9 – 2.2)

1.2 (0.8, 1.9)

1.5 (1.0, 2.3)

Proposed RA Cutpoints

 

 

 

   BMI ≥ 24.7 men; 26.1 women

55%

67%

53%

   Risk Ratio

2.3 (1.5, 3.4)

2.8 (1.9, 4.1)

2.2 (1.5, 3.3)


Disclosure:

I. Colmegna,
None;

M. C. Bazan Bardales,
None;

S. J. Bartlett,
None;

C. A. Hitchon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-prevalence-of-obesity-among-early-and-established-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology